News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Richard Gregory
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/24/2020 |
4
| Richard Gregory (Chief Commerical Officer) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Granted 7,500 options to buy
@ $8.18, valued at
$61.4k
|
|
| 03/15/2019 |
4
| Richard Gregory (Chief Commerical Officer) has filed a Form 4 on Interpace Diagnostics Group, Inc.|
Txns:
| Granted 39,528 shares
@ $0
Granted 158,112 options to buy
@ $0.98, valued at
$154.9k
|
|
| 03/08/2019 |
4/A
| Richard Gregory (Chief Commerical Officer) has filed a Form 4 on Interpace Diagnostics Group, Inc.|
Txns:
| Granted 13,400 shares
@ $0
Granted 53,600 options to buy
@ $1.08, valued at
$57.9k
|
|
| 12/06/2018 |
4
| Richard Gregory (Chief Commerical Officer) has filed a Form 4 on Interpace Diagnostics Group, Inc.|
Txns:
| Granted 67,000 options to buy
@ $1.08, valued at
$72.4k
|
|
| 03/09/2018 |
4
| Richard Gregory (Chief Commerical Officer) has filed a Form 4 on Interpace Diagnostics Group, Inc.|
Txns:
| Granted 28,000 shares
@ $0
Exercised 2,000 restricted stock units
@ $0
Granted 112,000 options to buy
@ $1.01, valued at
$113.1k
|
|
|
|